Case Study: International Biopharmaceutical Company achieves faster validated analytics, improved visibility and cost reduction with TIBCO Software

Specialty Biopharmaceutical Company Discovers Data Analysis and Process Efficiencies

An international specialty biopharmaceutical company’s U.S. Rare Diseases Business Unit was struggling with a patchwork of in‑house scripts and manual tools to aggregate critical production process data. That approach was cumbersome, time-consuming, and risky for FDA‑regulated manufacturing, requiring significant coding and staff effort to produce validated, auditable analyses.

The division implemented the TIBCO Statistica validated analytics platform across development, validation, and production environments at multiple sites, providing a single off‑the‑shelf solution for controlled access to validated data and workflows. The system empowered users to aggregate data, build models, and auto‑publish reports; enabled faster deployments to support six product lines; improved compliance, visibility, and risk detection; and delivered measurable gains—35–75% cost reductions and a reduction in model development time from four months to about 16 hours—resulting in higher quality and productivity.